A newly developed antibody drug reactivates suppressed immune cells, decreasing the bovine leukemia virus (BLV) counts in an infected cow. The antibody could be applied to treat a variety of intractable infectious diseases in cows.
A newly developed antibody drug reactivates suppressed immune cells, decreasing the bovine leukemia virus (BLV) counts in an infected cow. The antibody could be applied to treat a variety of intractable infectious diseases in cows.